A short and efficient enantiomeric synthesis of antitumor fused tetrahydrofurans

European Journal of Organic Chemistry

Volumn , Issue 8, 2006, Pages 1910-1916

  Crisóstomo, Fernando R Pinacho ^a,c   Padrón, José M ^a,b,c   Martín, Tomás ^a,c,d   Villar, Jesús ^b   Martín, Víctor S ^a,c  

^a UNIVERSIDAD DE LA LAGUNA   (Spain)

^b HOSPITAL UNIVERSITARIO NUESTRA SEÑORA DE CANDELARIA   (Spain)

^c Red Tematica de Investigacion Cooperativa en Cancer   (Spain)

^d INSTITUTO DE PRODUCTOS NATURALES Y AGROBIOLOGÍA   (Spain)

Author keywords

Antitumor agents; Asymmetric synthesis; Cyclic ethers; Structure activity relationships

Indexed keywords

EID: 33646165773     PISSN: 1434193X     EISSN: 10990690     Source Type: Journal    
DOI: 10.1002/ejoc.200500842     Document Type: Article

References (26)

1. Accessible via the Internet at http://dtp.nci.nih.gov/.
2. T. Suzuki, K. Koizumi, M. Suzuki, E. Kurosawa, Chem. Lett. 1983, 1639-1642.
3. M. Suzuki, E. Kurosawa, Phytochemistry 1985, 24, 1999-2002.
4. T. A. Grese, K. D. Hutchinson, L. E. Overman, J. Org. Chem. 1993, 58, 2468-2477.
5. a) O. J. Donadel, T. Martín, V. S. Martín, J. Villar, J. M. Padrón, Bioorg. Med. Chem. Lett. 2005, 15, 3536-3539;
6. b) J. M. Padrón, D. Tejedor, A. Santos-Expósito, F. García-Tellado, V. S. Martín, J. Villar, Bioorg. Med. Chem. Lett. 2005, 15, 2487-2490.
7. a) C. García, T. Martín, V. S. Martín, J. Org. Chem. 2001, 66, 1420-1428;
8. b) T. Martín, M. A. Soler, J. M. Betancort, V. S. Martín, J. Org. Chem. 1997, 62, 1570-1571.
9. For recent syntheses of THFs, see: a) J. A. Marshall, J. J. Sabatini, Org. Lett. 2005, 7, 4819-4822;
10. b) M. C. Elliott, J. Chem. Soc., Perkin Trans. 1 2002, 2301-2323, and references therein.
11. a) T. Katsuki, K. B. Sharpless, J. Am. Chem. Soc. 1980, 102, 5974-5976;
12. b) T. Kasutki, V. S. Martín, Organic Reactions (Ed.: L. A. Paquette), John Wiley & Sons, New York, 1996, vol, 48, pp. 1-299.
13. H. C. Kolb, M. S. Van Nieuwenhze, K. B. Sharpless, Chem. Rev. 1994, 94, 2483-2547.
14. C. S. Poss, S. L. Schreiber, Acc. Chem. Res. 1994, 27, 9-17.
15. Y. Gao, R. M. Hanson, J. M. Klunder, S. Y. Ko, H. Masamune, K. B. Sharpless, J. Am. Chem. Soc. 1987, 109, 5765-5780.
16. T. R. Hoye, J. C. Suhadolnik, J. Am. Chem. Soc. 1985, 107, 5312-5313.
17. P. Skehan, P. Storeng, D. Scudeiro, A. Monks, J. McMahon, D. Vistica, J. T. Warren, H. Bokesch, S. Kenney, M. R. Boyd, J. Natl. Cancer Inst. 1990, 82, 1107-1112.
18. P. E. Pizao, G. J. Peters, J. van Ark-Otte, L. A. Smets, E. Smitskamp-Wilms, B. Winograd, H. M. Pinedo, G. Giaccone, Eur. J. Cancer A 1993, 29, 1566-1573.
19. The octanol/water partition coefficient expressed in logarithmic form (CLOGP) has been widely used for calculating drug lipophilicity. It is usually calculated from the sum of the partition coefficients of the chemical fragments composing the molecule. Software-predicted lipophilicity of the compounds was calculated with the CLOGP program accessible via the Internet (www.daylight.com/daycgi/clogp) working with Hansch-Leo's "fragment constant" method.
20. W. K. Anderson, R. Kasliwal, D. M. Houston, Y.-s. Wang, V. L. Narayanan, R. D. Haugwitz, J. Plowman, J. Med. Chem. 1995, 38, 3789-3797.
21. A. M. Van Hattum, H. M. Pinedo, H. M. M. Schlüper, F. H. Hausheer, E. Boven, Int. J. Cancer 2000, 88, 260-266.
22. L. G. Israels, E. D. Israels, Stem Cells 1999, 17, 306-313.
23. a) M. J. Arends, A. H. Wyllie, Int. Rev. Exp. Pathol. 1991, 32, 223-254;
24. b) P. Mesner, I. Budihardjo, S. H. Kaufmann, Adv. Pharmacol. 1997, 41, 461-499;
25. c) K. M. Debatin, Toxicol. Lett. 2000, 112-113, 41-48.
26. W. L. F. Armarego, D. D. Perrin, Purification of Laboratory Chemicals, 4th ed., Butterworth-Heinemann, Oxford, 1996.